Your browser doesn't support javascript.
loading
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations.
Curigliano, G; Lenihan, D; Fradley, M; Ganatra, S; Barac, A; Blaes, A; Herrmann, J; Porter, C; Lyon, A R; Lancellotti, P; Patel, A; DeCara, J; Mitchell, J; Harrison, E; Moslehi, J; Witteles, R; Calabro, M G; Orecchia, R; de Azambuja, E; Zamorano, J L; Krone, R; Iakobishvili, Z; Carver, J; Armenian, S; Ky, B; Cardinale, D; Cipolla, C M; Dent, S; Jordan, K.
Afiliação
  • Curigliano G; European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haematology (DIPO), University of Milan, Milan, Italy.
  • Lenihan D; Cardiovascular Division, Cardio-Oncology Center of Excellence, Washington University Medical Center, St. Louis, USA.
  • Fradley M; Cardio-oncology Program, Division of Cardiovascular Medicine, Morsani College of Medicine and H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, USA.
  • Ganatra S; Cardio-Oncology Program, Lahey Medical Center, Burlington.
  • Barac A; Cardio-Oncology Program, Medstar Heart and Vascular Institute and MedStar Georgetown Cancer Institute, Georgetown University Hospital, Washington DC, USA.
  • Blaes A; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, USA.
  • Herrmann J; Mayo Clinic College of Medicine, Rochester, USA.
  • Porter C; University of Kansas Medical Center, Lawrence, USA.
  • Lyon AR; Royal Brompton Hospital and Imperial College, London, UK.
  • Lancellotti P; GIGA Cardiovascular Sciences, Acute Care Unit, Heart Failure Clinic, CHU Sart Tilman, University Hospital of Liège, Liège, Belgium.
  • Patel A; Morsani College of Medicine, University of South Florida, Tampa, USA.
  • DeCara J; Medicine Section of Cardiology, University of Chicago, Chicago, USA.
  • Mitchell J; Washington University Medical Center, St. Louis, USA.
  • Harrison E; HCA Memorial Hospital and University of South Florida, Tampa, USA.
  • Moslehi J; Vanderbilt University School of Medicine, Nashville, USA.
  • Witteles R; Division of Cardiovascular Medicine, Falk CVRC, Stanford University School of Medicine, Stanford, USA.
  • Calabro MG; Department of Anesthesia and Intensive Care, IRCCS, San Raffaele Scientific Institute, Milan, Italy.
  • Orecchia R; European Institute of Oncology IRCCS, Milan, Italy.
  • de Azambuja E; Institut Jules Bordet and L'Université Libre de Bruxelles, Brussels, Belgium.
  • Zamorano JL; University Hospital Ramon y Cajal, Madrid, Spain.
  • Krone R; Division of Cardiology, Washington University, St. Louis, USA.
  • Iakobishvili Z; Clalit Health Services, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Carver J; Division of Cardiology, Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, USA.
  • Armenian S; Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte, USA.
  • Ky B; University of Pennsylvania School of Medicine, Philadelphia, USA.
  • Cardinale D; Cardioncology Unit, European Institute of Oncology, IRCCS, Milan, Italy.
  • Cipolla CM; Cardiology Department, European Institute of Oncology, IRCCS, Milan, Italy.
  • Dent S; Duke Cancer Institute, Duke University, Durham, USA.
  • Jordan K; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.
Ann Oncol ; 31(2): 171-190, 2020 02.
Article em En | MEDLINE | ID: mdl-31959335

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cardiopatias / Neoplasias / Antineoplásicos Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cardiopatias / Neoplasias / Antineoplásicos Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article